ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0004. ProtoKinetix shares last traded at $0.0004, with a volume of 550,000 shares.
ProtoKinetix Stock Performance
About ProtoKinetix
ProtoKinetix Inc is a biotechnology company focused on developing synthetic glycopeptide compounds designed to support cell survival, adhesion and regeneration. Its lead compound, PKX-001, is an amino acid glycopeptide intended to replicate certain protective and regenerative properties associated with naturally occurring biological molecules.
The company has investigated PKX-001 for potential applications in areas including wound healing, tissue repair, cell and gene therapy, organ preservation, ophthalmology and other regenerative medicine uses.
Further Reading
- Five stocks we like better than ProtoKinetix
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
